The super-rich in the US are usually 'makers' whose innovations benefited many--but may also harm many if the 'makers' become 'takers'
Deaton's view 👇 #UBSCenterForum
Deaton presents insights from his research on educational inequality. Inequality in education and health may actually bother people more than income and wealth inequality. #UBSCenterForum
Education is beneficial for health and life expectancy. #UBSCenterForum
What to do? Deaton picks up some ideas for regulation by Eric Posner. #UBSCenterForum
The discussion of solutions to the #inequality problem continues in the Q&A session. According to Deaton, big companies paying all their taxes is the crucial first step, much more important than philanthropic help. #UBSCenterForum#EconomicsForSociety
Deaton criticizes heavily the role of the pharma industry in the opioid epidmic. They may or may not redeem themselves with the development of a Covid #vaccine. #UBSCenterForum
Final question: Will #inequality be the coffin nail of #democracy? Deaton: key is to prevent that 2/3 of people feel as exploited workers while 1/3 cash in. This sensation might also be a reason for so many people supporting Trump. #UBSCenterForum#EconomicsForSociety
• • •
Missing some Tweet in this thread? You can try to
force a refresh
To kick off the discussion, @BrankoMilan talks about the development of inequality over time. Inequality between countries peaked in the early 2000s, declining in the last 20 years due to the rise of Asia (though still at a high level). #UBSCenterForum
Currie and Dorn report from their respective research that both health inequality (measured by mortality rates) and income inequality are more pronounced in the US than in Europe (France/Switzerland). Can these differences be explained by in the different political systems?
My first publication also deserves my first proper tweet. Our paper on economic incentives and p-hacking in clinical trials just came out in @PNASNews pnas.org/content/early/… (1/6)
We analyze p-values from nearly 5000 phase II and phase III drug trials reported to ClinicalTrials.gov, the largest registry of clinical trials. Do financial conflicts of interest undermine ethical standards and incentivize manipulation of results? (2/6)
Unlike previous studies of academic publications in many disciplines (including economics), we don’t find patterns suggestive of p-hacking--reassuring in times where the whole world looks hopefully at trials for #COVID__19 medications/vaccines. (3/6)